Related Experiment Video
Updated: Jun 12, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction
G Corona1, G Rastrelli, V Boddi
1Andrology Unit and Endocrinology, Department of Clinical Physiopathology, University of Florence, Florence, Italy.
International Journal of Andrology
|June 5, 2010
Summary
Higher prolactin (PRL) levels in men with erectile dysfunction (ED) are linked to a lower incidence of major cardiovascular events (MACE). This finding suggests a protective role for PRL in cardiovascular health for at-risk populations.
Area of Science:
- Endocrinology
- Cardiology
- Men's Health
Background:
- The physiological role of prolactin (PRL) in men remains unclear.
- Previous research linked lower PRL to adverse metabolic profiles and erectile dysfunction (ED).
Purpose of the Study:
- To investigate the association between PRL levels and incident major cardiovascular events (MACE) in men with ED.
Main Methods:
- Analysis of PRL levels and MACE incidence in subjects with ED, excluding pathological hyperprolactinemia and pituitary diseases.
- Statistical analysis to determine the risk of MACE based on PRL levels, including quintile and incremental analyses.
Main Results:
- Subjects in the highest PRL quintile (12-35 ng/mL) showed a significantly lower incidence of MACE compared to others.
- Each 10 ng/mL increase in PRL was associated with a 5% reduction in MACE risk (p=0.03).
- No significant MACE difference was observed when comparing hyperprolactinemia patients with controls.
Conclusions:
- Elevated PRL plasma levels are associated with a reduced risk of MACE in men with ED, independent of other cardiovascular risk factors.
- This suggests a potential protective cardiovascular role for PRL in men experiencing ED.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:27Psychoneuroimmunology: Cardiovascular Disease
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...